Phio Pharmaceuticals (PHIO) Total Current Liabilities (2016 - 2021)
Historic Total Current Liabilities for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q3 2021 value amounting to $2.5 million.
- Phio Pharmaceuticals' Total Current Liabilities rose 1188.34% to $2.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $2.5 million, marking a year-over-year increase of 1188.34%. This contributed to the annual value of $2.2 million for FY2020, which is 1680.85% up from last year.
- As of Q3 2021, Phio Pharmaceuticals' Total Current Liabilities stood at $2.5 million, which was up 1188.34% from $2.6 million recorded in Q2 2021.
- In the past 5 years, Phio Pharmaceuticals' Total Current Liabilities ranged from a high of $2.8 million in Q2 2018 and a low of $1.5 million during Q1 2019
- Moreover, its 5-year median value for Total Current Liabilities was $2.2 million (2020), whereas its average is $2.2 million.
- Its Total Current Liabilities has fluctuated over the past 5 years, first surged by 8550.37% in 2017, then plummeted by 3991.28% in 2019.
- Over the past 5 years, Phio Pharmaceuticals' Total Current Liabilities (Quarter) stood at $2.3 million in 2017, then decreased by 23.0% to $1.7 million in 2018, then increased by 7.8% to $1.9 million in 2019, then increased by 16.81% to $2.2 million in 2020, then rose by 13.62% to $2.5 million in 2021.
- Its Total Current Liabilities was $2.5 million in Q3 2021, compared to $2.6 million in Q2 2021 and $2.2 million in Q1 2021.